Abstract
Zusammenfassung. Chronische Depressionen sind häufige und besonders beeinträchtigende Erkrankungen. Aufgrund der Dauer und einer Vielzahl von komplizierenden Faktoren gelten sie als schwierig zu behandeln. In den gängigen Leitlinien wird eine Kombination von Psychotherapie und Antidepressiva zur Therapie empfohlen. Dabei hat sich eine störungsspezifische Behandlung mit dem Cognitive Behavioral Analysis System of Psychotherapy (CBASP) anderen und unspezifischeren Ansätzen gegenüber als überlegen gezeigt. Bei dieser Therapieform wird gezielt auf die Besonderheiten chronischer Verlaufsformen wie auf frühe interpersonelle Traumatisierungen, hohe Komorbiditätsraten und ausgeprägtes Vermeidungsverhalten eingegangen. Eine längerfristige Behandlung mit CBASP führte zu besseren Behandlungserfolgen.
Abstract. Chronic depression is a highly prevalent and particularly disabling disorder. Due to the duration and a variety of complicating factors, chronic depression counts as difficult-to-treat. In treatment guidelines, a combination of psychotherapy and antidepressants is recommended for the treatment of persistent depressive disorders. Among different forms of psychotherapy, a disorder-specific treatment with the Cognitive Behavioral Analysis System of Psychotherapy (CBASP) proved superior over other and more unspecific approaches. CBASP focuses on the special needs of chronic forms of depression such as early trauma, high comorbidity rates, and marked avoidance behavior. A longer term treatment with CBASP led to better outcomes.
Literatur
(2014). Predictors of remission from chronic depression: a prospective study in a nationally representative sample. Comprehensive Psychiatry, 55, 463–467.
(2010). The epidemiology of chronic major depressive disorder and dysthymic disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry, 71, 1645–1656.
(2013). How much psychotherapy is needed to treat depression? A metaregression analysis. Journal of Affective Disorders, 149, 1–13.
(2010). Psychotherapy for chronic major depression and dysthymia: a meta-analysis. Clinical Psychology Review, 30, 51–62.
Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde (DGPPN) . (2015). S3-Leitlinien unipolare Depression. Darmstadt: Steinkopff.(2012). Childhood maltreatment and differential treatment response and recurrence in adult major depressive disorder. Journal of Consulting and Clinical Psychology, 80, 342–353.
(2016). European Psychiatric Association Guidance on psychotherapy in chronic depression across Europe. European Psychiatry, 33, 18–36.
(2000). A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. New England Journal of Medicine, 342, 1462–1470.
(2015). The association of childhood trauma and personality disorders with chronic depression: A cross-sectional study in depressed outpatients. Journal of Clinical Psychiatry, 76, e794–801.
(2008). Chronic forms of major depression are still undertreated in the 21st century: systematic assessment of 801 patients presenting for treatment. Journal of Affective Disorders, 110, 55–61.
;REVAMP Investigators . (2009). Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP trial. Archives of General Psychiatry, 66, 1178–1188.(2014). Efficacy and acceptability of acute treatments for persistent depressive disorder: a network meta-analysis. Depression and Anxiety, 8, 621–630.
(1975). Comparative Studies of Psychotherapies: Is it true that “everyone has won and all must have prichttps://de.wikipedia.org/wiki/Archives_of_General_Psychiatryes”?Archives of General Psychiatry, 32, 995–1008.
(2003). Patient’s therapeutic skill acquisition and response to psychotherapy, alone or in combination with medication. Psychological Medicine, 33, 693–702.
(2015). CBASP as a Distinctive Treatment for Persistent Depressive Disorder: Distinctive features. New York: Routledge.
(2015). A randomized controlled trial on the efficacy of mindfulness-based cognitive therapy and a group version of cognitive behavioral analysis system of psychotherapy for chronically depressed patients. Journal of Consulting and Clinical Psychology, 83, 951–963.
(2012). Prevalence and correlates of the proposed DSM-5 diagnosis of chronic depressive disorder. Journal of Affective Disorders, 139, 172–180.
(2003). Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. Proc Natl Acad Sci USA, 100, 14293–14296.
(2009). Prevalence and correlates of chronic depression in the Canadian community health survey: mental health and well-being. Canadian Journal of Psychiatry, 54, 389–398.
(2017). Effect of disorder-specific vs nonspecific psychotherapy for chronic depression: A randomized clinical trial. JAMA Psychiatry, 74, 233–242.
(2015). Cognitive behavioral analysis system of psychotherapy versus escitalopram in chronic major depression. Psychotherapy and Psychosomatics, 84, 227–240.
(2011). Cognitive behavioral analysis system of psychotherapy versus interpersonal psychotherapy for early-onset chronic depression: a randomized pilot study. Journal of Affective Disorders, 129, 109–116.
(2014). Cognitive behavioral therapy for depressed adolescents exposed to interpersonal trauma: An initial effectiveness trial. Psychotherapy, 51, 167–179.
(2013). Psychotherapy, antidepressants, and their combination for chronic major depressive disorder: a systematic review. Canadian Journal of Psychiatry, 58, 386–392.
(2012). Patient treatment preference as a predictor of response and attrition in treatment for chronic depression. Depression and Anxiety, 10, 896–905.
(2014). The effectiveness of the cognitive behavioral analysis system of psychotherapy for chronic depression: a randomized controlled trial. Psychotherapy and Psychosomatics, 83, 263–269.